We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
PANalytical Launched New Compact Benchtop XRF System
Product News

PANalytical Launched New Compact Benchtop XRF System

PANalytical Launched New Compact Benchtop XRF System
Product News

PANalytical Launched New Compact Benchtop XRF System


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "PANalytical Launched New Compact Benchtop XRF System"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

PANalytical has launched a new Epsilon 1 XRF (X-ray fluorescence) analyzer at last year’s meeting of the American Association of Pharmaceutical Sciences (AAPS), November 2-6, in San Diego, California.

Designed as the most powerful benchtop spectrometer in its class, the new Epsilon 1 provides a compact and cost-effective ‘out-of-the-box’ pre-calibrated solution for the analysis of residual catalysts in pharmaceutical materials.

Metal catalysts are used as part of the pharmaceutical development and manufacturing processes. Post-process efforts are made to remove the undesired catalyst from the material but there are often residues remaining.

These residues require comprehensive quantification to meet stringent industry permissible limits, such as those specified in pharmacopoeias including the United States pharmacopoeia and the European pharmacopoeia. The Epsilon 1 will set the new benchmark for analytical performance and ease of use in this class of industry-dedicated XRF instrumentation.

“The need for pharmaceutical catalyst analysis is an industry-wide concern,” commented Pieter de Groot, PANalytical Corporate Marketing Director. “The Epsilon 1 offers a pre-calibrated total solution package, including installation qualification and operation qualification procedures. Designed with simplicity in mind, for the first time PANalytical’s high standards of analysis are now available in this class of desktop instruments.”

Advertisement